LCTX
Lineage Cell Therapeutics Inc
0.9274$
-0.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.8% | +7.4% | -5.2% | -6.0% | +17.2% | -1.3% | -18.8% | -1.3% | +25.6% | -2.7% | -3.0% | |
| – | -11.6% | +18.9% | -11.7% | -14.8% | +48.2% | -2.0% | -12.3% | -3.6% | +40.0% | -5.1% | -5.7% | |
| – | +12.6% | +23.0% | -32.0% | -6.3% | +65.0% | +4.6% | -11.7% | -4.3% | +0.8% | -11.9% | +3.9% | |
| – | -14.1% | +22.9% | -11.7% | -15.0% | +46.1% | +0.2% | -11.7% | -4.3% | +37.8% | -4.3% | -4.8% | |
| – | +72.5% | -89.7% | +205.2% | +72.3% | +57.5% | -66.6% | +20.2% | -50.4% | +1,129.9% | -48.4% | -2.0% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -0.1% | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -31.9% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -1.3% | -3.9% | -4.2% | -11.5% | +13.9% | -5.8% | +28.1% | +57.6% | +0.6% | -17.9% | -18.3% | |
| – | +13.1% | -6.0% | -9.6% | -9.2% | +0.8% | -6.4% | -17.8% | -12.8% | +21.2% | -28.3% | -1.6% | |
| – | -5.8% | +24.8% | +1.3% | +2.0% | +1.3% | +2.4% | -11.2% | +1.7% | -20.0% | +1.4% | +9.9% | |
| – | -15.6% | +7.9% | +8.0% | -33.0% | -26.6% | +69.9% | -25.0% | +1.5% | +54.0% | +137.8% | -72.4% | |
| – | -6.9% | +14.2% | -5.7% | -3.1% | +18.4% | +0.8% | -38.8% | -54.4% | +102.1% | +20.9% | +13.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.3% | +5.9% | +3.2% | +0.0% | +6.0% | +12.9% | +1.0% | +0.2% | +0.6% | +13.5% | +0.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.